Multicenter trial validates continuous pregnancy-to-postpartum mobile health coaching programNovember 13, 2026
DNA methylation profiling stratifies recurrence risk in low-grade endometrial cancerNovember 13, 2026
Research FDA orders new warning labels for GLP-1 drugs over rare vision-loss riskBy Healthcare Propulsion StaffNovember 12, 20260 FRESNO, Calif. (FOX26) — The U.S. Food and Drug Administration (FDA) identified a potential risk of a rare eye condition…
